Bolt Biotherapeutics extends lease
- Paid $1.0 million to Landlord
- Lease expires Dec 31, 2027
- Potential $4.5 million termination payment
BOLT
Bolt Biotherapeutics, Inc. SEC filings
Every EDGAR filing for Bolt Biotherapeutics, Inc. (BOLT), newest first, with AI summaries and stories.
- Ticker
- BOLT
- CIK
- 1641281
- Sector
- Biotech and pharma
- Latest filing
- Oct 8
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KBolt Biotherapeutics, Inc.BOLTLIVE ROUTINE4Bolt Biotherapeutics, Inc.BOLTLIVE 3 insider filings
Grant Yonehiro, insider filing for BOLT
Show all 3
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
Grant Yonehiro, reporting
ROUTINESCHEDULE 13GBolt Biotherapeutics, Inc.BOLTLIVE Ownership stake disclosure by RENAISSANCE TECHNOLOGIES LLC
RENAISSANCE TECHNOLOGIES LLC, filed by
NOTABLE10-QBolt Biotherapeutics, Inc.BOLTLIVE ROUTINE8-KBolt Biotherapeutics, Inc.BOLTLIVE ROUTINE4Bolt Biotherapeutics, Inc.BOLTLIVE 5 insider filings
Laura Berner, insider filing for BOLT
Show all 5
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
Laura Berner, reporting
ROUTINE8-KBolt Biotherapeutics, Inc.BOLTLIVE ROUTINE8-KBolt Biotherapeutics, Inc.BOLTLIVE NOTABLE10-QBolt Biotherapeutics, Inc.BOLTLIVE ROUTINEARSBolt Biotherapeutics, Inc.BOLTLIVE ROUTINEDEFA14ABolt Biotherapeutics, Inc.BOLTLIVE ROUTINEDEF 14ABolt Biotherapeutics, Inc.BOLTLIVE ROUTINES-8Bolt Biotherapeutics, Inc.BOLTLIVE NOTABLE10-KBolt Biotherapeutics, Inc.BOLTLIVE ROUTINE8-KBolt Biotherapeutics, Inc.BOLTLIVE NOTABLESCHEDULE 13D/ABolt Biotherapeutics, Inc.BOLTLIVE Ownership stake disclosure by Pivotal bioVenture Partners Fund I, L.P. (amended)
Pivotal bioVenture Partners Fund I, L.P., filed by
NOTABLESCHEDULE 13D/ABolt Biotherapeutics, Inc.BOLTLIVE Ownership stake disclosure by Pivotal bioVenture Partners Fund I, L.P. (amended)
Pivotal bioVenture Partners Fund I, L.P., filed by
ROUTINESCHEDULE 13G/ABolt Biotherapeutics, Inc.BOLTLIVE Ownership stake disclosure by Vivo Panda Fund, L.P. (amended)
Vivo Panda Fund, L.P., filed by
ROUTINE4Bolt Biotherapeutics, Inc.BOLTLIVE 3 insider filings
William P. Quinn, insider filing for BOLT
Show all 3
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
William P. Quinn, reporting
ROUTINE4Bolt Biotherapeutics, Inc.BOLTLIVE 8 insider filings
Jakob Dupont, insider filing for BOLT
Show all 8
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
- 4Insider filing for BOLT
Jakob Dupont, reporting
ROUTINESCHEDULE 13G/ABolt Biotherapeutics, Inc.BOLTLIVE 2 13G filings
Ownership stake disclosure by TANG CAPITAL MANAGEMENT LLC (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
TANG CAPITAL MANAGEMENT LLC, filed by
NOTABLE10-QBolt Biotherapeutics, Inc.BOLTLIVE ROUTINE8-KBolt Biotherapeutics, Inc.BOLTLIVE